CAREZ

Serial Number 87667536
Registration 6428543
700

Registration Progress

Application Filed
Nov 1, 2017
Under Examination
May 29, 2018
Approved for Publication
Apr 3, 2018
Published for Opposition
Apr 3, 2018
Registered
Jul 20, 2021

Trademark Image

CAREZ

Basic Information

Serial Number
87667536
Registration Number
6428543
Filing Date
November 1, 2017
Registration Date
July 20, 2021
Published for Opposition
April 3, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 20, 2021
Registration
Registered
Classes
036 044

Rights Holder

CSL Behring L.L.C.

16
Address
1020 First Avenue
King of Prussia, PA 194060901

Ownership History

CSL Behring L.L.C.

Original Applicant
16
King of Prussia, PA

CSL Behring L.L.C.

Owner at Publication
16
King of Prussia, PA

CSL Behring L.L.C.

Original Registrant
16
King of Prussia, PA

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
577 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210720)
Due Date
July 20, 2027
Grace Period Ends
January 20, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

41 events
Date Code Type Description Documents
Jul 20, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 15, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 14, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 27, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 24, 2021 IUAF S USE AMENDMENT FILED Loading...
May 24, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 10, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 9, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 29, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 9, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 29, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 7, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 3, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 3, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 3, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 12, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 8, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 8, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 8, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 14, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 10, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 10, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
May 10, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 17, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 15, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 15, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 15, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 29, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 3, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 3, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 14, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 27, 2018 ALIE A ASSIGNED TO LIE Loading...
Feb 20, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 20, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 20, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 20, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 20, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 13, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 10, 2017 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 9, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 4, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 036
Providing assistance to patients diagnosed with alpha-1 antitrypsin deficiency regarding obtaining approval, authorization, and verification of insurance coverage for treatment, determining existing insurance benefits, and appealing from denial of insurance coverage and acquiring letters of medical necessity for insurance coverage; Providing information for patients diagnosed with alpha-1 antitrypsin deficiency regarding medication reimbursement programs
First Use Anywhere: 20210400
First Use in Commerce: 20210400
Class 044
Providing medical information for patients diagnosed with alpha-1 antitrypsin deficiency regarding available resources and treatments and steps and actions for healthy living; providing medical counseling, mentoring and guidance for patients with alpha-1 antitrypsin deficiency; and providing medical services through charitable actions, namely, continuance of medication for those who are underinsured, uninsured, or who have experienced a lapse in insurance coverage
First Use Anywhere: 20210400
First Use in Commerce: 20210400

Additional Information

Design Mark
The mark consists of "CareZ" with a cloud design above the "areZ".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
CARES

Classification

International Classes
036 044